What non‑anticholinergic sleep aid can be used instead of hydroxyzine, which is causing dry eyes and dry mouth?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Alternative Sleep Aid for Hydroxyzine-Induced Anticholinergic Side Effects

Switch to ramelteon (8 mg) for sleep onset problems or low-dose doxepin (3-6 mg) for sleep maintenance issues, as both lack anticholinergic properties and are guideline-recommended alternatives. 1

Why These Specific Agents

Hydroxyzine causes dry eyes and dry mouth through its anticholinergic mechanism 2, so you need a non-anticholinergic alternative. The 2017 American Academy of Sleep Medicine guidelines provide clear direction here:

For Sleep Onset Insomnia:

  • Ramelteon (8 mg) is a melatonin receptor agonist with zero anticholinergic activity 1
  • Works through the circadian system rather than sedation
  • No dry mouth, dry eyes, or cognitive impairment
  • Weak recommendation but appropriate given the need to avoid anticholinergics

For Sleep Maintenance Insomnia:

  • Low-dose doxepin (3-6 mg) is uniquely free of anticholinergic effects at these specific low doses 1
  • At 3-6 mg, it selectively blocks histamine H1 receptors without the anticholinergic burden seen at higher antidepressant doses
  • Particularly effective for the latter third of the night 3
  • This is critical: higher doses DO cause anticholinergic effects, so staying at 3-6 mg is essential

Other Guideline-Supported Options

If ramelteon or low-dose doxepin are ineffective or unavailable:

Non-benzodiazepine hypnotics (all with weak recommendations) 1:

  • Zolpidem (10 mg) - for both sleep onset and maintenance
  • Eszopiclone (2-3 mg) - for both sleep onset and maintenance
  • Zaleplon (10 mg) - for sleep onset only
  • Suvorexant (10-20 mg) - orexin antagonist for sleep maintenance

Benzodiazepines (if other options fail):

  • Temazepam (15 mg) - for both sleep onset and maintenance 1
  • Triazolam (0.25 mg) - for sleep onset only 1

What to Avoid

The AASM explicitly recommends AGAINST these commonly used agents 1:

  • Diphenhydramine - another antihistamine with anticholinergic effects (would replicate your problem)
  • Trazodone - despite widespread off-label use, insufficient efficacy data
  • Melatonin - over-the-counter formulations lack evidence
  • Valerian, tryptophan - insufficient evidence

Critical Pitfalls

  1. Don't use another antihistamine - diphenhydramine or doxylamine would cause the same anticholinergic side effects as hydroxyzine 1

  2. Dose matters for doxepin - only 3-6 mg doses are anticholinergic-free; higher doses will cause dry mouth and dry eyes 3

  3. Consider cognitive behavioral therapy for insomnia (CBT-I) - the 2016 American College of Physicians guideline strongly recommends CBT-I as first-line treatment before or alongside pharmacotherapy 4, 1

  4. Assess the type of insomnia - sleep onset versus maintenance determines which agent is most appropriate 1

Practical Algorithm

  1. Identify insomnia pattern: Sleep onset difficulty vs. sleep maintenance vs. both
  2. First choice based on pattern:
    • Sleep onset → Ramelteon 8 mg
    • Sleep maintenance → Doxepin 3-6 mg
    • Both → Eszopiclone 2-3 mg or Zolpidem 10 mg
  3. If ineffective after 2-4 weeks, consider alternative from guideline-recommended list
  4. Simultaneously refer for CBT-I if available 4, 1

The evidence quality for all pharmacologic agents is weak due to publication bias and limited long-term data 1, but ramelteon and low-dose doxepin specifically address your anticholinergic side effect concern while maintaining guideline support.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.